Optimizing the Care and Quality of Life for Patients with ADPKD – Part 2: Progression and Prognostication

ReachMD CME
05/08/2021

Listen "Optimizing the Care and Quality of Life for Patients with ADPKD – Part 2: Progression and Prognostication "

Descargar episodio Ver en sitio original

Episode Synopsis

CME credits: 0.50

Claim your CME credit at https://reachmd.com/programs/cme/clinical-significance-imaging-management-adpkd/12678/



This Expert Exchange webcast aims to improve clinicians’ ability to properly monitor disease progression and make treatment decisions based on prognostic indicators.=

More episodes of the podcast ReachMD CME

Understanding Endocrine Resistance in HR+/HER2- mBC 07/10/2025
PI3K Pathway Inhibition in HR+/HER2- mBC: Mechanistic Insights 07/10/2025
Comprehensive Biomarker Testing in mBC Informs Clinical Decision Making 07/10/2025
Double Take: Pivotal Data Evaluating PI3K Inhibitor/Endocrine Therapy Regimens in mBC 07/10/2025
Triple Threat: Key Data on Simultaneous Estrogen, CDK4/6, and PI3K Inhibition in mBC 07/10/2025
Case in Point: Applying PI3K Combinations in Early Recurrent HR+/HER2- mBC 07/10/2025
PI3K Pathway Inhibitors: Safety and Tolerability Profiles 07/10/2025
The Future of PI3K Inhibition in HR+/HER2- Breast Cancer 07/10/2025
FSGS: When Solutions Fall Short 19/09/2025
Current FSGS Treatment Landscape: More Questions Than Answers 19/09/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA